RCKT — Rocket Pharmaceuticals, Inc.

Ownership history in MPM BioImpact LLC  ·  6 quarters on record

This page tracks every 13F SEC filing in which MPM BioImpact LLC reported a position in Rocket Pharmaceuticals, Inc. (RCKT). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
2.95% (2024 Q3)
Avg. % of fund
1.83%
First filed
2024 Q3
Last filed
2025 Q4
Quarters held
6
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 REDUCED 1,586,076 -2,317,305 -59.4% 0.64% $5.6M $3.51
2025 Q3 ADDED 3,903,381 +300 +0.0% 2.08% $12.7M $3.26
2025 Q2 ADDED 3,903,081 +2,284,816 +141.2% 1.66% $9.6M $2.45
2025 Q1 ADDED 1,618,265 +597,706 +58.6% 1.86% $10.8M $6.67
2 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    RCKT price (monthly, adj. close)

Other funds also holding RCKT

As of 2025 Q4 — sorted by position size

Monaco Asset Management SAM 3Y 1.82% Lion Point Capital, LP 3Y 7Y 1.56% M28 Capital Management LP 3Y 0.98% Newtyn Management, LLC 3Y 7Y 0.98% Amitell Capital Pte Ltd 3Y 0.7% RTW INVESTMENTS, LP 3Y 7Y 0.62% Prosight Management, LP 3Y 7Y 0.54% Opaleye Management Inc. 3Y 7Y 0.44% MONIMUS CAPITAL MANAGEMENT, LP 0.32% SUVRETTA CAPITAL MANAGEMENT, LLC 3Y 7Y 0.22%
← Back to MPM BioImpact LLC Holdings